Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

National Football League demands interviews with four players named in PED report

Published 07/23/2016, 01:55 AM
Updated 07/23/2016, 01:55 AM
© Reuters. NFL: NFC Championship-Green Bay Packers at Seattle Seahawks

(Reuters) - The National Football League has rejected written statements from four players named in a report alleging use of performance-enhancing drugs as sufficient cooperation and will need to interview them, the league said on its website on Friday.

Pittsburgh's James Harrison and Green Bay players Clay Matthews, Julius Peppers and Mike Neal have given written statements regarding a December report by Al Jazeera America that they received the illegal drugs from an anti-aging clinic.

The NFL Players Association has argued that there should be no need to interview someone based on an allegation that has no proven merit.

"The league responded to the union this afternoon confirming receipt of written statements by Matthews, Peppers, Harrison and Mike Neal," the NFL website cited an unnamed source as saying on Friday in a report.

"The league rejected the union's view that affidavits constitute reasonable cooperation by the players and confirmed that they are required to participate in in-person interviews."

The NFL will start with interviewing Neal, and plans to speak to Harrison, Matthews and Peppers on the first day of their respective training camps.

The Al Jazeera report cited a former unpaid Guyer Institute intern pharmacist, Charlie Sly, who allegedly spoke to an undercover reporter working for the network.

© Reuters. NFL: NFC Championship-Green Bay Packers at Seattle Seahawks

Sly later recanted his statements about the players receiving the drugs, and Harrison said he has never met him in an affidavit obtained earlier this month.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.